{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,10]],"date-time":"2026-11-10T17:05:54Z","timestamp":1794330354767,"version":"4.9.0"},"reference-count":128,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","journal-of-hepatology.eu","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Hepatology"],"published-print":{"date-parts":[[2021,8]]},"DOI":"10.1016\/j.jhep.2021.04.029","type":"journal-article","created":{"date-parts":[[2021,4,27]],"date-time":"2021-04-27T13:24:38Z","timestamp":1619529878000},"page":"442-453","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":217,"title":["Current knowledge and management of portal vein thrombosis in cirrhosis"],"prefix":"10.1016","volume":"75","author":[{"given":"Marco","family":"Senzolo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6175-8216","authenticated-orcid":false,"given":"Guadalupe","family":"Garcia-Tsao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan Carlos","family":"Garc\u00eda-Pag\u00e1n","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jhep.2021.04.029_bib1","doi-asserted-by":"crossref","first-page":"1491","DOI":"10.1055\/s-0038-1666861","article-title":"Concepts and controversies in haemostasis and thrombosis associated with liver disease: proceedings of the 7th international coagulation in liver disease conference","volume":"118","author":"Intagliata","year":"2018","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.jhep.2021.04.029_bib2","doi-asserted-by":"crossref","first-page":"1154","DOI":"10.1111\/j.1365-2036.2010.04454.x","article-title":"The epidemiology and clinical features of portal vein thrombosis: a multicentre study","volume":"32","author":"Rajani","year":"2010","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.jhep.2021.04.029_bib3","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1111\/j.1365-2036.2009.04182.x","article-title":"Systematic review: portal vein thrombosis in cirrhosis","volume":"31","author":"Tsochatzis","year":"2010","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.jhep.2021.04.029_bib4","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1055\/s-0038-1676981","article-title":"Incidence and recurrence of portal vein thrombosis in cirrhotic patients","volume":"119","author":"Violi","year":"2019","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.jhep.2021.04.029_bib5","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.trre.2014.01.003","article-title":"Portal vein thrombosis and liver transplantation: implications for waiting list period, surgical approach, early and late follow-up","volume":"28","author":"Ponziani","year":"2014","journal-title":"Transpl Rev (Orlando)"},{"key":"10.1016\/j.jhep.2021.04.029_bib6","first-page":"166","article-title":"Clinical impact and risk factors of portal vein thrombosis for patients on wait list for liver transplant","volume":"16","author":"Montenovo","year":"2018","journal-title":"Exp Clin Transpl"},{"key":"10.1016\/j.jhep.2021.04.029_bib7","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1097\/TP.0b013e31826e8e53","article-title":"Management of nonneoplastic portal vein thrombosis in the setting of liver transplantation: a systematic review","volume":"94","author":"Rodriguez-Castro","year":"2012","journal-title":"Transplantation"},{"key":"10.1016\/j.jhep.2021.04.029_bib8","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1016\/j.jhep.2009.03.013","article-title":"Thrombotic risk factors in patients with liver cirrhosis: correlation with MELD scoring system and portal vein thrombosis development","volume":"51","author":"Zocco","year":"2009","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.jhep.2021.04.029_bib9","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1038\/ajg.2012.452","article-title":"De novo portal vein thrombosis in virus-related cirrhosis: predictive factors and long-term outcomes","volume":"108","author":"Maruyama","year":"2013","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.jhep.2021.04.029_bib10","doi-asserted-by":"crossref","first-page":"952","DOI":"10.1016\/S1665-2681(19)31301-8","article-title":"Impact of untreated portal vein thrombosis on pre and post liver transplant outcomes in cirrhosis","volume":"12","author":"John","year":"2013","journal-title":"Ann Hepatol"},{"key":"10.1016\/j.jhep.2021.04.029_bib11","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1097\/MEG.0000000000000325","article-title":"De-novo portal vein thrombosis in liver cirrhosis: risk factors and correlation with the model for End-stage Liver Disease scoring system","volume":"27","author":"Abdel-Razik","year":"2015","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"10.1016\/j.jhep.2021.04.029_bib12","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1002\/hep.27546","article-title":"Causes and consequences of portal vein thrombosis in 1,243 patients with cirrhosis: results of a longitudinal study","volume":"61","author":"Nery","year":"2015","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2021.04.029_bib13","doi-asserted-by":"crossref","DOI":"10.1053\/j.gastro.2012.07.018","article-title":"Enoxaparin prevents portal vein thrombosis and liver decompensation in patients with advanced cirrhosis","volume":"143","author":"Villa","year":"2012","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jhep.2021.04.029_bib14","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1016\/j.dld.2016.12.019","article-title":"Thromboelastometry hypercoagulable profiles and portal vein thrombosis in cirrhotic patients with hepatocellular carcinoma","volume":"49","author":"Zanetto","year":"2017","journal-title":"Dig Liver Dis"},{"key":"10.1016\/j.jhep.2021.04.029_bib15","doi-asserted-by":"crossref","first-page":"914","DOI":"10.1097\/MEG.0000000000000351","article-title":"Efficacy and safety of anticoagulation therapy with different doses of enoxaparin for portal vein thrombosis in cirrhotic patients with hepatitis B","volume":"27","author":"Cui","year":"2015","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"10.1016\/j.jhep.2021.04.029_bib16","doi-asserted-by":"crossref","first-page":"1459","DOI":"10.1111\/liv.14121","article-title":"Incidence, predictive factors and clinical significance of development of portal vein thrombosis in cirrhosis: a prospective study","volume":"39","author":"Noronha Ferreira","year":"2019","journal-title":"Liver Int"},{"key":"10.1016\/j.jhep.2021.04.029_bib17","doi-asserted-by":"crossref","DOI":"10.1016\/j.jhep.2021.07.020","article-title":"Predicting portal thrombosis in cirrhosis: a prospective comprehensive study of clinical, ultrasonografic and hemostatic factors","author":"Turon","year":"2021","journal-title":"J\u00a0Hep"},{"key":"10.1016\/j.jhep.2021.04.029_bib18","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1111\/apt.15137","article-title":"Nonselective beta-blockers and the risk of portal vein thrombosis in patients with cirrhosis: results of a prospective longitudinal study","volume":"49","author":"Nery","year":"2019","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.jhep.2021.04.029_bib19","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1111\/liv.13500","article-title":"Decreased portal vein velocity is predictive of the development of portal vein thrombosis: a matched case-control study","volume":"38","author":"Stine","year":"2018","journal-title":"Liver Int"},{"key":"10.1016\/j.jhep.2021.04.029_bib20","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/j.jhep.2011.12.034","article-title":"Portal vein thrombosis, cirrhosis, and liver transplantation","volume":"57","author":"Francoz","year":"2012","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.jhep.2021.04.029_bib21","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1007\/s12072-019-09951-6","article-title":"Nonselective beta-blockers and development of portal vein thrombosis in liver cirrhosis: a systematic review and meta-analysis","volume":"13","author":"Xu","year":"2019","journal-title":"Hepatol Int"},{"key":"10.1016\/j.jhep.2021.04.029_bib22","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1056\/NEJMra1011170","article-title":"The coagulopathy of chronic liver disease","volume":"365","author":"Tripodi","year":"2011","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jhep.2021.04.029_bib23","doi-asserted-by":"crossref","first-page":"1322","DOI":"10.1111\/liv.13087","article-title":"Resistance to thrombomodulin is associated with de novo portal vein thrombosis and low survival in patients with cirrhosis","volume":"36","author":"La Mura","year":"2016","journal-title":"Liver Int"},{"key":"10.1016\/j.jhep.2021.04.029_bib24","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1002\/rth2.12253","article-title":"Inherited thrombophilia and portal vein thrombosis in cirrhosis: a systematic review and meta-analysis","volume":"3","author":"Ma","year":"2019","journal-title":"Res Pract Thromb Haemost"},{"key":"10.1016\/j.jhep.2021.04.029_bib25","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1097\/MBC.0000000000000901","article-title":"The utility of thrombophilia testing in patients with newly diagnosed portal vein thrombosis","volume":"31","author":"Tremblay","year":"2020","journal-title":"Blood Coagul Fibrinol"},{"key":"10.1016\/j.jhep.2021.04.029_bib26","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1007\/s11239-014-1124-z","article-title":"Thrombophilic factor analysis in cirrhotic patients with portal vein thrombosis","volume":"40","author":"Saugel","year":"2015","journal-title":"J\u00a0Thromb Thrombol"},{"key":"10.1016\/j.jhep.2021.04.029_bib27","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1097\/MEG.0000000000000022","article-title":"JAK2 exon 12 mutations were not found in liver transplant recipients with or without pretransplant portal vein thrombosis","author":"Ayala","year":"2014","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"10.1016\/j.jhep.2021.04.029_bib28","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/j.jhep.2015.07.040","article-title":"Vascular diseases of the liver","volume":"64","year":"2016","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.jhep.2021.04.029_bib29","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/j.thromres.2007.10.009","article-title":"Incidence, risk factors and consequences of portal vein and systemic thromboses in hepatocellular carcinoma","volume":"122","author":"Connolly","year":"2008","journal-title":"Thromb Res"},{"key":"10.1016\/j.jhep.2021.04.029_bib30","doi-asserted-by":"crossref","first-page":"950","DOI":"10.1016\/j.jhep.2017.07.002","article-title":"Gut-derived endotoxin stimulates factor VIII secretion from endothelial cells. Implications for hypercoagulability in cirrhosis","volume":"67","author":"Carnevale","year":"2017","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.jhep.2021.04.029_bib31","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1182\/blood.V78.2.410.410","article-title":"Interleukin-4 counteracts pyrogen-induced downregulation of thrombomodulin in cultured human vascular endothelial cells","volume":"78","author":"Kapiotis","year":"1991","journal-title":"Blood"},{"key":"10.1016\/j.jhep.2021.04.029_bib32","doi-asserted-by":"crossref","first-page":"1535","DOI":"10.1136\/gutjnl-2019-319044","article-title":"Role of portal venous platelet activation in patients with decompensated cirrhosis and TIPS","author":"Queck","year":"2020","journal-title":"Gut"},{"key":"10.1016\/j.jhep.2021.04.029_bib33","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1055\/s-0040-1713169","article-title":"Endothelial damage of the portal vein is associated with heparin-like effect in advanced stages of cirrhosis","volume":"120","author":"Shalaby","year":"2020","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.jhep.2021.04.029_bib34","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1002\/hep.510310213","article-title":"Inherited coagulation disorders in cirrhotic patients with portal vein thrombosis","volume":"31","author":"Amitrano","year":"2000","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2021.04.029_bib35","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1007\/BF02208603","article-title":"Portal vein thrombosis following endoscopic variceal sclerotherapy. Prospective controlled comparison in patients with cirrhosis","volume":"41","author":"Politoske","year":"1996","journal-title":"Dig Dis Sci"},{"key":"10.1016\/j.jhep.2021.04.029_bib36","doi-asserted-by":"crossref","first-page":"9216172","DOI":"10.1155\/2017\/9216172","article-title":"The best anticoagulation strategy for cirrhotic patients who underwent splenectomy: a Network meta-analysis","volume":"2017","author":"Gong","year":"2017","journal-title":"Gastroenterol Res Pract"},{"key":"10.1016\/j.jhep.2021.04.029_bib37","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1097\/TP.0000000000000785","article-title":"Portal vein thrombosis is a risk factor for poor early outcomes after liver transplantation: analysis of risk factors and outcomes for portal vein thrombosis in waitlisted patients","volume":"100","author":"Ghabril","year":"2016","journal-title":"Transplantation"},{"key":"10.1016\/j.jhep.2021.04.029_bib38","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.1002\/lt.24134","article-title":"Increased risk of portal vein thrombosis in patients with cirrhosis due to nonalcoholic steatohepatitis","volume":"21","author":"Stine","year":"2015","journal-title":"Liver Transpl"},{"key":"10.1016\/j.jhep.2021.04.029_bib39","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/j.jhep.2014.03.013","article-title":"Procoagulant imbalance in patients with non-alcoholic fatty liver disease","volume":"61","author":"Tripodi","year":"2014","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.jhep.2021.04.029_bib40","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.dld.2016.11.013","article-title":"Portal vein thrombosis: the role of imaging in the clinical setting","volume":"49","author":"Margini","year":"2017","journal-title":"Dig Liver Dis"},{"key":"10.1016\/j.jhep.2021.04.029_bib41","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.2214\/ajr.165.5.7572494","article-title":"Cavernous transformation of the portal vein: patterns of intrahepatic and splanchnic collateral circulation detected with Doppler sonography","volume":"165","author":"De Gaetano","year":"1995","journal-title":"AJR Am J Roentgenol"},{"key":"10.1016\/j.jhep.2021.04.029_bib42","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/j.jhep.2019.02.015","article-title":"Current knowledge in pathophysiology and management of Budd-Chiari syndrome and non-cirrhotic non-tumoral splanchnic vein thrombosis","volume":"71","author":"Hern\u00e1ndez-Gea","year":"2019","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.jhep.2021.04.029_bib43","doi-asserted-by":"crossref","first-page":"293","DOI":"10.2214\/ajr.157.2.1853809","article-title":"Diagnosis of portal vein thrombosis: value of color Doppler imaging","volume":"157","author":"Tessler","year":"1991","journal-title":"AJR Am J Roentgenol"},{"key":"10.1016\/j.jhep.2021.04.029_bib44","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1148\/radiology.154.3.3881793","article-title":"Portal thrombosis: dynamic CT features and course","volume":"154","author":"Mathieu","year":"1985","journal-title":"Radiology"},{"key":"10.1016\/j.jhep.2021.04.029_bib45","doi-asserted-by":"crossref","first-page":"14","DOI":"10.2214\/AJR.18.19548","article-title":"Portal vein thrombosis: imaging the spectrum of disease with an emphasis on MRI features","volume":"211","author":"Jha","year":"2018","journal-title":"AJR Am J Roentgenol"},{"key":"10.1016\/j.jhep.2021.04.029_bib46","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1002\/lt.25345","article-title":"Distinguishing tumor from bland portal vein thrombus in liver transplant candidates with hepatocellular carcinoma: the A-VENA criteria","volume":"25","author":"Sherman","year":"2019","journal-title":"Liver Transpl"},{"key":"10.1016\/j.jhep.2021.04.029_bib47","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1097\/00000658-199103000-00003","article-title":"The spectrum of portal vein thrombosis in liver transplantation","volume":"213","author":"Stieber","year":"1991","journal-title":"Ann Surg"},{"key":"10.1016\/j.jhep.2021.04.029_bib48","doi-asserted-by":"crossref","first-page":"1195","DOI":"10.1002\/hep.1840160515","article-title":"The incidence of portal vein\u00a0thrombosis at liver transplantation","volume":"16","author":"Nonami","year":"1992","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2021.04.029_bib49","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1006\/jsre.1996.0053","article-title":"A\u00a0high incidence of native portal vein thrombosis in veterans undergoing liver transplantation","volume":"60","author":"Gayowski","year":"1996","journal-title":"J\u00a0Surg Res"},{"key":"10.1016\/j.jhep.2021.04.029_bib50","doi-asserted-by":"crossref","first-page":"1873","DOI":"10.1097\/00007890-200005150-00023","article-title":"Portal vein thrombosis in adults undergoing liver transplantation: risk factors, screening, management, and outcome","volume":"69","author":"Yerdel","year":"2000","journal-title":"Transplantation"},{"key":"10.1016\/j.jhep.2021.04.029_bib51","doi-asserted-by":"crossref","first-page":"1772","DOI":"10.1097\/00007890-200005150-00006","article-title":"Changing perspectives in portal vein thrombosis and liver transplantation","volume":"69","author":"Jamieson","year":"2000","journal-title":"Transplantation"},{"key":"10.1016\/j.jhep.2021.04.029_bib52","doi-asserted-by":"crossref","first-page":"3904","DOI":"10.1016\/j.transproceed.2005.09.120","article-title":"Portal vein thrombosis in liver transplantation","volume":"37","author":"Charco","year":"2005","journal-title":"Transpl Proc"},{"key":"10.1016\/j.jhep.2021.04.029_bib53","doi-asserted-by":"crossref","first-page":"1544","DOI":"10.1002\/lt.20869","article-title":"The role of TIPS for portal vein patency in liver transplant patients with portal vein thrombosis","volume":"12","author":"Bauer","year":"2006","journal-title":"Liver Transpl"},{"key":"10.1016\/j.jhep.2021.04.029_bib54","doi-asserted-by":"crossref","DOI":"10.1053\/j.gastro.2016.08.033","article-title":"Toward a comprehensive new classification of portal vein thrombosis in patients with cirrhosis","volume":"151","author":"Sarin","year":"2016","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jhep.2021.04.029_bib55","doi-asserted-by":"crossref","first-page":"1038","DOI":"10.1016\/j.jhep.2019.08.012","article-title":"Novel classification of non-malignant portal vein thrombosis: a guide to surgical decision-making during liver transplantation","volume":"71","author":"Bhangui","year":"2019","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.jhep.2021.04.029_bib56","doi-asserted-by":"crossref","first-page":"1873","DOI":"10.1097\/00007890-200005150-00023","article-title":"Portal vein thrombosis in adults undergoing liver transplantation: risk factors, screening, management, and outcome","volume":"69","author":"Yerdel","year":"2000","journal-title":"Transplantation"},{"key":"10.1016\/j.jhep.2021.04.029_bib57","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1148\/radiol.2015150369","article-title":"Is post-TIPS anticoagulation therapy necessary in patients with cirrhosis and portal vein thrombosis? A randomized controlled trial","volume":"279","author":"Wang","year":"2016","journal-title":"Radiology"},{"key":"10.1016\/j.jhep.2021.04.029_bib58","doi-asserted-by":"crossref","DOI":"10.1053\/j.gastro.2017.04.042","article-title":"Effects of anticoagulants in patients with cirrhosis and portal vein thrombosis: a systematic review and meta-analysis","volume":"153","author":"Loffredo","year":"2017","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jhep.2021.04.029_bib59","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1148\/radiol.12112236","article-title":"Natural course of extrahepatic nonmalignant partial portal vein thrombosis in patients with cirrhosis","volume":"265","author":"Luca","year":"2012","journal-title":"Radiology"},{"key":"10.1016\/j.jhep.2021.04.029_bib60","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1111\/j.1478-3231.2012.02785.x","article-title":"Prospective evaluation of anticoagulation and transjugular intrahepatic portosystemic shunt for the management of portal vein thrombosis in cirrhosis","volume":"32","author":"Senzolo","year":"2012","journal-title":"Liver Int"},{"key":"10.1016\/j.jhep.2021.04.029_bib61","doi-asserted-by":"crossref","first-page":"E107","DOI":"10.1111\/hepr.12934","article-title":"Antithrombin III for portal vein thrombosis in patients with liver disease: a randomized, double-blind, controlled trial","volume":"48","author":"Hidaka","year":"2018","journal-title":"Hepatol Res"},{"key":"10.1016\/j.jhep.2021.04.029_bib62","doi-asserted-by":"crossref","DOI":"10.1016\/j.cgh.2020.02.037","article-title":"Prevalence and clinical significance of portal vein thrombosis in patients with cirrhosis and acute decompensation","author":"Zhang","year":"2020","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.jhep.2021.04.029_bib63","doi-asserted-by":"crossref","first-page":"1474","DOI":"10.1001\/jamainternmed.2015.3184","article-title":"Long-term clinical outcomes of splanchnic vein thrombosis: results\u00a0of an international registry","volume":"175","author":"Ageno","year":"2015","journal-title":"JAMA Intern Med"},{"key":"10.1016\/j.jhep.2021.04.029_bib64","doi-asserted-by":"crossref","first-page":"1409","DOI":"10.1053\/gast.2002.36391","article-title":"Portal and mesenteric venous thrombosis in cirrhotic patients","author":"Amitrano","year":"2002","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jhep.2021.04.029_bib65","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1097\/MCG.0b013e318254e9d4","article-title":"Hypoxic hepatitis occurring in cirrhosis after variceal bleeding: still a lethal disease","volume":"46","author":"Amitrano","year":"2012","journal-title":"J\u00a0Clin Gastroenterol"},{"key":"10.1016\/j.jhep.2021.04.029_bib66","doi-asserted-by":"crossref","first-page":"1872","DOI":"10.1038\/ajg.2012.313","article-title":"The effectiveness of current acute variceal bleed treatments in unselected cirrhotic patients: refining short-term prognosis and risk factors","volume":"107","author":"Amitrano","year":"2012","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.jhep.2021.04.029_bib67","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1053\/jhep.2003.50385","article-title":"Upper digestive bleeding in cirrhosis. Post-therapeutic outcome and prognostic indicators","volume":"38","author":"D'Amico","year":"2003","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2021.04.029_bib68","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1016\/j.dld.2009.08.009","article-title":"Systemic thrombolysis of portal vein thrombosis in cirrhotic patients: a pilot study","volume":"42","author":"De Santis","year":"2010","journal-title":"Dig Liver Dis"},{"key":"10.1016\/j.jhep.2021.04.029_bib69","doi-asserted-by":"crossref","DOI":"10.14309\/ctg.0000000000000026","article-title":"Portal vein thrombosis in decompensated cirrhosis: rationale for treatment","volume":"10","author":"Senzolo","year":"2019","journal-title":"Clin Transl Gastroenterol"},{"key":"10.1016\/j.jhep.2021.04.029_bib70","doi-asserted-by":"crossref","DOI":"10.1016\/j.cgh.2017.10.016","article-title":"Harmful and beneficial effects of anticoagulants in patients with cirrhosis and portal vein thrombosis","volume":"16","author":"La Mura","year":"2018","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.jhep.2021.04.029_bib71","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1016\/j.cgh.2012.01.012","article-title":"Efficacy and safety of anticoagulation on patients with cirrhosis and portal vein thrombosis","volume":"10","author":"Delgado","year":"2012","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.jhep.2021.04.029_bib72","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1038\/s41424-018-0043-2","article-title":"Long-term outcome of splanchnic vein thrombosis in cirrhosis","volume":"9","author":"Senzolo","year":"2018","journal-title":"Clin Transl Gastroenterol"},{"key":"10.1016\/j.jhep.2021.04.029_bib73","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1038\/s41395-018-0421-0","article-title":"Clinical impact and safety of anticoagulants for portal vein thrombosis in cirrhosis","volume":"114","author":"Pettinari","year":"2019","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.jhep.2021.04.029_bib74","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1016\/j.jhep.2015.12.003","article-title":"Enoxaparin reduces hepatic vascular resistance and portal pressure in cirrhotic rats","volume":"64","author":"Cerini","year":"2016","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.jhep.2021.04.029_bib75","doi-asserted-by":"crossref","first-page":"2031","DOI":"10.1002\/hep.29084","article-title":"The anticoagulant rivaroxaban lowers portal hypertension in cirrhotic rats mainly by deactivating hepatic stellate cells","volume":"65","author":"Vilaseca","year":"2017","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2021.04.029_bib76","article-title":"Mortality and hepatic decompensation in patients with cirrhosis and atrial fibrillation treated with anticoagulation","author":"Serper","year":"2020","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2021.04.029_bib77","article-title":"Anticoagulant treatment for splanchnic vein thrombosis in liver cirrhosis: a systematic review and meta-analysis","author":"Valeriani","year":"2021","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.jhep.2021.04.029_bib78","doi-asserted-by":"crossref","first-page":"1318","DOI":"10.1111\/tri.13353","article-title":"Mortality in liver transplant recipients with portal vein thrombosis - an updated meta-analysis","volume":"31","author":"Zanetto","year":"2018","journal-title":"Transpl Int"},{"key":"10.1016\/j.jhep.2021.04.029_bib79","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1097\/SLA.0b013e318206818b","article-title":"Portal vein thrombosis and liver transplantation: evolution during 10 years of experience at the University of Bologna","volume":"253","author":"Ravaioli","year":"2011","journal-title":"Ann Surg"},{"key":"10.1016\/j.jhep.2021.04.029_bib80","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1097\/MCG.0b013e3181b3ab44","article-title":"Safety and efficacy of anticoagulation therapy with low molecular weight heparin for portal vein thrombosis in patients with liver cirrhosis","volume":"44","author":"Amitrano","year":"2010","journal-title":"J\u00a0Clin Gastroenterol"},{"key":"10.1016\/j.jhep.2021.04.029_bib81","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1097\/MEG.0000000000001237","article-title":"A\u00a0prediction model for successful anticoagulation in cirrhotic portal vein thrombosis","volume":"31","author":"Rodriguez-Castro","year":"2019","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"10.1016\/j.jhep.2021.04.029_bib82","doi-asserted-by":"crossref","first-page":"1776","DOI":"10.1007\/s10620-012-2548-y","article-title":"Portal vein thrombosis in patients with end stage liver disease awaiting liver transplantation: outcome of anticoagulation","volume":"58","author":"Werner","year":"2013","journal-title":"Dig Dis Sci"},{"key":"10.1016\/j.jhep.2021.04.029_bib83","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1097\/MEG.0000000000000482","article-title":"Efficacy and safety of anticoagulation in more advanced portal vein thrombosis in patients with liver cirrhosis","volume":"28","author":"Chen","year":"2016","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"10.1016\/j.jhep.2021.04.029_bib84","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1007\/s00508-018-1351-y","article-title":"Anticoagulation in non-malignant portal vein thrombosis is safe and improves hepatic function","volume":"130","author":"Scheiner","year":"2018","journal-title":"Wien Klin Wochenschr"},{"key":"10.1016\/j.jhep.2021.04.029_bib85","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.thromres.2018.01.032","article-title":"Low-molecular-weight heparin treatment for portal vein thrombosis in liver cirrhosis: efficacy and the risk of hemorrhagic complications","volume":"163","author":"Kwon","year":"2018","journal-title":"Thromb Res"},{"key":"10.1016\/j.jhep.2021.04.029_bib86","article-title":"Fondaparinux is effective for acute portal vein thrombosis in decompensated cirrhotic patients","volume":"96","author":"Zhang","year":"2017","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.jhep.2021.04.029_bib87","doi-asserted-by":"crossref","first-page":"1208","DOI":"10.1016\/j.dld.2016.06.027","article-title":"Coagulation parameters in patients with cirrhosis and portal vein thrombosis treated sequentially with low molecular weight heparin and vitamin K antagonists","volume":"48","author":"Tripodi","year":"2016","journal-title":"Dig Liver Dis"},{"key":"10.1016\/j.jhep.2021.04.029_bib88","doi-asserted-by":"crossref","first-page":"384","DOI":"10.3350\/cmh.2014.20.4.384","article-title":"Safety, efficacy, and response predictors of anticoagulation for the treatment of nonmalignant portal-vein thrombosis in patients with cirrhosis: a propensity score matching analysis","volume":"20","author":"Chung","year":"2014","journal-title":"Clin Mol Hepatol"},{"key":"10.1016\/j.jhep.2021.04.029_bib89","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1186\/s12876-019-1140-8","article-title":"Danaparoid sodium-based anticoagulation therapy for portal vein thrombosis in cirrhosis patients","volume":"19","author":"Hayashi","year":"2019","journal-title":"BMC Gastroenterol"},{"key":"10.1016\/j.jhep.2021.04.029_bib90","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1111\/hepr.12400","article-title":"Efficacy and safety of the anticoagulant drug, danaparoid sodium, in the treatment of portal vein thrombosis in patients with liver cirrhosis","volume":"45","author":"Naeshiro","year":"2015","journal-title":"Hepatol Res"},{"key":"10.1016\/j.jhep.2021.04.029_bib91","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1016\/j.clinre.2018.11.011","article-title":"Portal vein thrombosis and liver cirrhosis: long-term anticoagulation is effective and safe","volume":"43","author":"Berg\u00e8re","year":"2019","journal-title":"Clin Res Hepatol Gastroenterol"},{"key":"10.1016\/j.jhep.2021.04.029_bib92","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1016\/j.gastrohep.2018.06.005","article-title":"Efficacy and safety of anticoagulation in non-malignant portal vein thrombosis in patients with liver cirrhosis","volume":"41","author":"Artaza","year":"2018","journal-title":"Gastroenterol Hepatol"},{"key":"10.1016\/j.jhep.2021.04.029_bib93","article-title":"Association between portal vein thrombosis and survival of liver transplant recipients: a systematic review and meta-analysis of observational studies","volume":"24","author":"Qi","year":"2015","journal-title":"J\u00a0Gastrointestin Liver Dis"},{"key":"10.1016\/j.jhep.2021.04.029_bib94","doi-asserted-by":"crossref","first-page":"18","DOI":"10.14309\/ajg.0000000000000486","article-title":"ACG clinical guideline: disorders of the hepatic and mesenteric circulation","volume":"115","author":"Simonetto","year":"2020","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.jhep.2021.04.029_bib95","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1016\/j.dld.2010.11.006","article-title":"Vascular disorders of the liver: recommendations from the Italian Association for the Study of the Liver (AISF) ad hoc committee","volume":"43","author":"Senzolo","year":"2011","journal-title":"Dig Liver Dis"},{"key":"10.1016\/j.jhep.2021.04.029_bib96","first-page":"820","article-title":"Optimal length of anticoagulant therapy in cirrhotic patients with portal vein thrombosis","author":"Rodr\u00edguez-Castro","year":"2012","journal-title":"Clin\u00a0Gastroenterol Hepatol"},{"key":"10.1016\/j.jhep.2021.04.029_bib97","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1111\/j.1478-3231.2010.02358.x","article-title":"Low-molecular-weight heparin in patients with advanced cirrhosis","volume":"31","author":"Bechmann","year":"2011","journal-title":"Liver Int"},{"key":"10.1016\/j.jhep.2021.04.029_bib98","doi-asserted-by":"crossref","first-page":"1823","DOI":"10.1111\/j.1538-7836.2012.04824.x","article-title":"Increased anticoagulant response to low-molecular-weight heparin in plasma from patients with advanced cirrhosis","volume":"10","author":"Senzolo","year":"2012","journal-title":"J\u00a0Thromb Haemost"},{"key":"10.1016\/j.jhep.2021.04.029_bib99","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/bs.pmbts.2019.02.004","article-title":"The clinical use of Fondaparinux: a synthetic heparin pentasaccharide","volume":"163","author":"Zhang","year":"2019","journal-title":"Prog Mol Biol Transl Sci"},{"key":"10.1016\/j.jhep.2021.04.029_bib100","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1160\/TH07-04-0252","article-title":"Fondaparinux for the treatment of patients with acute heparin-induced thrombocytopenia","volume":"99","author":"Lobo","year":"2008","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.jhep.2021.04.029_bib101","doi-asserted-by":"crossref","DOI":"10.1016\/j.amjmed.2021.05.013","article-title":"Comparison of fondaparinux and low molecular weight heparin in the treatment of portal vein thrombosis in cirrhosis","author":"Senzolo","year":"2021","journal-title":"Am J Med"},{"key":"10.1016\/j.jhep.2021.04.029_bib102","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/j.jhepr.2019.02.006","article-title":"Anticoagulation in the cirrhotic patient","volume":"1","author":"Turco","year":"2019","journal-title":"JHEP Rep"},{"key":"10.1016\/j.jhep.2021.04.029_bib103","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.vph.2018.05.002","article-title":"Randomized controlled trial of rivaroxaban versus warfarin in the management of acute non-neoplastic portal vein thrombosis","volume":"113","author":"Hanafy","year":"2019","journal-title":"Vasc Pharmacol"},{"key":"10.1016\/j.jhep.2021.04.029_bib104","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1111\/liv.13285","article-title":"Antithrombotic treatment with direct-acting oral anticoagulants in patients with splanchnic vein thrombosis and cirrhosis","volume":"37","author":"De Gottardi","year":"2017","journal-title":"Liver Int"},{"key":"10.1016\/j.jhep.2021.04.029_bib105","doi-asserted-by":"crossref","first-page":"499","DOI":"10.3350\/cmh.2016.0016","article-title":"Recurrent acute portal vein thrombosis in liver\u00a0cirrhosis treated by rivaroxaban","volume":"22","author":"Yang","year":"2016","journal-title":"Clin Mol Hepatol"},{"key":"10.1016\/j.jhep.2021.04.029_bib106","doi-asserted-by":"crossref","first-page":"1721","DOI":"10.1007\/s10620-015-4012-2","article-title":"Direct oral anticoagulants in cirrhosis patients pose similar risks of bleeding when compared to traditional anticoagulation","volume":"61","author":"Intagliata","year":"2016","journal-title":"Dig Dis Sci"},{"key":"10.1016\/j.jhep.2021.04.029_bib107","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1111\/hepr.12895","article-title":"Efficacy and safety of edoxaban for treatment of portal vein thrombosis following danaparoid sodium in patients with liver cirrhosis","volume":"48","author":"Nagaoki","year":"2018","journal-title":"Hepatol Res"},{"key":"10.1016\/j.jhep.2021.04.029_bib108","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejim.2020.03.005","article-title":"Anticoagulation in thrombocytopenic patients with hematological malignancy: a multinational clinical vignette-based experiment","author":"Leader","year":"2020","journal-title":"Eur J Intern Med"},{"key":"10.1016\/j.jhep.2021.04.029_bib109","doi-asserted-by":"crossref","first-page":"3295","DOI":"10.1016\/j.jacc.2019.04.052","article-title":"Direct oral anticoagulants in patients with atrial fibrillation and liver disease","volume":"73","author":"Lee","year":"2019","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jhep.2021.04.029_bib110","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1016\/j.amjmed.2019.01.006","article-title":"Anticoagulation therapy in patients with liver cirrhosis is associated with an increased risk of variceal hemorrhage","volume":"132","author":"Sasso","year":"2019","journal-title":"Am J Med"},{"key":"10.1016\/j.jhep.2021.04.029_bib111","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1016\/j.jhep.2010.06.004","article-title":"Revising consensus in portal hypertension: report of the Baveno V consensus workshop on methodology of diagnosis and therapy in portal hypertension","volume":"53","author":"de Franchis","year":"2010","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.jhep.2021.04.029_bib112","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1002\/hep.28906","article-title":"Portal hypertensive bleeding in cirrhosis: risk stratification, diagnosis, and management: 2016 practice guidance by the American Association for the study of liver diseases","volume":"65","author":"Garcia-Tsao","year":"2017","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2021.04.029_bib113","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.1111\/liv.13728","article-title":"Low molecular weight heparin does not increase bleeding and mortality post-endoscopic variceal band ligation in cirrhotic patients","volume":"38","author":"Bianchini","year":"2018","journal-title":"Liver Int"},{"key":"10.1016\/j.jhep.2021.04.029_bib114","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1097\/MEG.0000000000001522","article-title":"Safety of variceal band ligation in patients with cirrhosis and portal vein thrombosis treated with anticoagulant therapy: a retrospective study","volume":"32","author":"Ponthus","year":"2020","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"10.1016\/j.jhep.2021.04.029_bib115","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1097\/MEG.0000000000001061","article-title":"Bleeding risk of variceal band ligation in extrahepatic portal vein obstruction is not increased by oral anticoagulation","volume":"30","author":"Guillaume","year":"2018","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"10.1016\/j.jhep.2021.04.029_bib116","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1148\/radiology.186.2.8421759","article-title":"Transjugular intrahepatic portosystemic shunts in patients with portal vein occlusion","volume":"186","author":"Radosevich","year":"1993","journal-title":"Radiology"},{"key":"10.1016\/j.jhep.2021.04.029_bib117","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/S1051-0443(98)70493-2","article-title":"Portal venous thrombosis: percutaneous therapy and outcome","volume":"9","author":"Walser","year":"1998","journal-title":"J\u00a0Vasc Interv Radiol"},{"key":"10.1016\/j.jhep.2021.04.029_bib118","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1016\/S1051-0443(99)70044-8","article-title":"Symptomatic spleno-mesenteric-portal venous thrombosis: recanalization and reconstruction with endovascular stents","volume":"10","author":"Stein","year":"1999","journal-title":"J\u00a0Vasc Interv Radiol"},{"key":"10.1016\/j.jhep.2021.04.029_bib119","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1111\/apt.15044","article-title":"Systematic review with meta-analysis: portal vein recanalisation and transjugular intrahepatic portosystemic shunt for portal vein thrombosis","volume":"49","author":"Rodrigues","year":"2019","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.jhep.2021.04.029_bib120","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1136\/gutjnl-2019-320221","article-title":"Transjugular intrahepatic portosystemic stent-shunt in the management of portal hypertension","volume":"69","author":"Tripathi","year":"2020","journal-title":"Gut"},{"key":"10.1016\/j.jhep.2021.04.029_bib121","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1136\/gut.2010.228023","article-title":"Short- and long-term effects of the transjugular intrahepatic portosystemic shunt on portal vein thrombosis in patients with cirrhosis","volume":"60","author":"Luca","year":"2011","journal-title":"Gut"},{"key":"10.1016\/j.jhep.2021.04.029_bib122","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.jhep.2010.06.029","article-title":"Transjugular intrahepatic portosystemic shunt for portal vein thrombosis with symptomatic portal hypertension in liver cirrhosis","volume":"54","author":"Han","year":"2011","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.jhep.2021.04.029_bib123","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1007\/s11547-020-01155-5","article-title":"Radiation exposure during transjugular intrahepatic portosystemic shunt creation in patients with complete portal vein thrombosis or portal cavernoma","volume":"125","author":"Miraglia","year":"2020","journal-title":"Radiol Med"},{"key":"10.1016\/j.jhep.2021.04.029_bib124","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1053\/j.tvir.2016.01.005","article-title":"Thrombolysis and transjugular intrahepatic portosystemic shunt creation for acute and\u00a0subacute portal vein thrombosis","volume":"19","author":"Chamarthy","year":"2016","journal-title":"Tech Vasc Interv Radiol"},{"key":"10.1016\/j.jhep.2021.04.029_bib125","doi-asserted-by":"crossref","first-page":"2156","DOI":"10.1136\/gutjnl-2017-314634","article-title":"Covered TIPS versus endoscopic band ligation plus propranolol for the prevention of variceal rebleeding in cirrhotic patients with portal vein thrombosis: a randomised controlled trial","volume":"67","author":"Lv","year":"2018","journal-title":"Gut"},{"key":"10.1016\/j.jhep.2021.04.029_bib126","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1148\/radiol.15141252","article-title":"Advanced cirrhosis\u00a0combined with portal vein thrombosis: a randomized trial of\u00a0TIPS versus\u00a0endoscopic band ligation plus propranolol for the prevention of recurrent esophageal variceal bleeding","volume":"276","author":"Luo","year":"2015","journal-title":"Radiology"},{"key":"10.1016\/j.jhep.2021.04.029_bib127","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.dld.2016.10.011","article-title":"Consensus conference on TIPS management: techniques, indications, contraindications","volume":"49","author":"Fagiuoli","year":"2017","journal-title":"Dig Liver Dis"},{"key":"10.1016\/j.jhep.2021.04.029_bib128","doi-asserted-by":"crossref","DOI":"10.1016\/j.jvir.2017.08.005","article-title":"Pretransplantation portal vein recanalization and transjugular intrahepatic portosystemic shunt creation for chronic portal vein thrombosis: final analysis of a 61-patient cohort","volume":"28","author":"Thornburg","year":"2017","journal-title":"J\u00a0Vasc Interv Radiol"}],"container-title":["Journal of Hepatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168827821002658?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168827821002658?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,29]],"date-time":"2025-09-29T19:43:40Z","timestamp":1759175020000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0168827821002658"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,8]]},"references-count":128,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2021,8]]}},"alternative-id":["S0168827821002658"],"URL":"https:\/\/doi.org\/10.1016\/j.jhep.2021.04.029","relation":{},"ISSN":["0168-8278"],"issn-type":[{"value":"0168-8278","type":"print"}],"subject":[],"published":{"date-parts":[[2021,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Current knowledge and management of portal vein thrombosis in cirrhosis","name":"articletitle","label":"Article Title"},{"value":"Journal of Hepatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jhep.2021.04.029","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Published by Elsevier B.V. on behalf of European Association for the Study of the Liver.","name":"copyright","label":"Copyright"}]}}